|
Real-time Estimate
Cboe BZX
12:13:29 06/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.025 USD | +0.49% |
|
-0.97% | -24.44% |
| 14/09 | Ocugen Insider Sold Shares Worth $589,110, According to a Recent SEC Filing | MT |
| 01/09 | Ocugen Doses First Patient in Trial of Potential Eye Disease Drug | MT |
| Market Cap | 35Cr 31Cr 29Cr 26Cr 49Cr 3.33TCr 50Cr 347.37Cr 135.15Cr 1.7TCr 129.85Cr 127.05Cr 5.46TCr | P/E 2026 * |
-3.95x | P/E 2027 * | -3.78x |
|---|---|---|---|---|---|
| Enterprise Value | 28Cr 25Cr 23Cr 21Cr 40Cr 2.69TCr 40Cr 280.48Cr 109.13Cr 1.37TCr 104.85Cr 102.58Cr 4.41TCr | EV / Sales 2026 * |
56.3x | EV / Sales 2027 * | 62.9x |
| Free-Float |
98.42% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| OCGN | Delayed | |
CBOE
| OCGN | Real-time | |
|
Tradegate
| 2H51 | Real-time | |
|
Boerse Muenchen
| 2H51 | Real-time | |
|
Deutsche Boerse AG
| 2H51 | Delayed | |
|
Börse Stuttgart
| 2H51 | Delayed | |
|
Mexican S.E.
| OCGN * | End-of-day quote |
Last Transcript: Ocugen, Inc.
| 1 day | +0.49% | ||
| 1 week | -0.97% | ||
| Current month | -0.97% | ||
| 1 month | -23.31% | ||
| 3 months | -31.54% | ||
| 6 months | -42.37% | ||
| Current year | -24.44% |
| 1 week | 1 |  | 1.1 |
| 1 month | 0.97 | | 1.36 |
| Current year | 0.97 | | 2.72 |
| 1 year | 0.97 | | 2.72 |
| 3 years | 0.34 | | 2.72 |
| 5 years | 0.34 | | 17.65 |
| 10 years | 0.17 | | 18.77 |
| Manager | Title | Age | Since |
|---|---|---|---|
Shankar Musunuri
CEO | Chief Executive Officer | 62 | 27/09/2019 |
| Director of Finance/CFO | - | 09/02/2026 | |
Paul Staid
COO | Chief Operating Officer | - | 01/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Shankar Musunuri
CHM | Chairman | 62 | 27/09/2019 |
Uday Kompella
BRD | Director/Board Member | 59 | 01/09/2013 |
Junge Zhang
BRD | Director/Board Member | 59 | 01/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 09/09/26 | Sell | Chief Executive Officer | -5,25,991 | 0.1551% | ||
| 01/04/26 | Exercice | Director | 3,88,268 | 0.1184% | ||
| 04/03/26 | Other | Chief Financial Officer | 12,50,350 | 0.3813% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | -0.97% | -43.96% | +146.62% | 35Cr | |
| +4.16% | +3.04% | +49.37% | +94.17% | 7.42TCr | |
| -0.37% | -3.81% | +19.51% | +78.12% | 5.74TCr | |
| +1.63% | -1.61% | +3.16% | +36.89% | 4.76TCr | |
| +0.74% | +3.49% | +348.24% | +726.56% | 4.43TCr | |
| +2.20% | -2.75% | +28.54% | +33.21% | 4.25TCr | |
| +0.59% | -1.70% | +4.71% | +111.38% | 4.07TCr | |
| -0.54% | +2.93% | +9.31% | +54.06% | 3.1TCr | |
| +1.56% | +4.53% | +31.34% | +26.92% | 2.85TCr | |
| +0.88% | -1.48% | -7.18% | -11.14% | 2.43TCr | |
| Average | +1.10% | -0.53% | +44.30% | +129.68% | 3.91TCr | |
| Weighted average by Cap. | +1.41% | -0.84% | +58.21% | +137.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 49.57L 44.22L 41.2L 37.49L 70.61L 48Cr 71.13L 4.98Cr 1.94Cr 24Cr 1.86Cr 1.82Cr 78Cr | 55L 49.07L 45.71L 41.6L 78.34L 53Cr 78.92L 5.52Cr 2.15Cr 27Cr 2.06Cr 2.02Cr 87Cr |
| Net income | -8.67Cr -7.73Cr -7.21Cr -6.56Cr -12Cr -834.9Cr -12Cr -87Cr -34Cr -426.12Cr -33Cr -32Cr -1.37TCr | -9.47Cr -8.44Cr -7.87Cr -7.16Cr -13Cr -911.56Cr -14Cr -95Cr -37Cr -465.24Cr -36Cr -35Cr -1.5TCr |
| Net Debt | -6.66Cr -5.94Cr -5.54Cr -5.04Cr -9.49Cr -641.4Cr -9.56Cr -67Cr -26Cr -327.36Cr -25Cr -24Cr -1.05TCr | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/26/05 | $1.020 | 0.00% | 38,42,935 |
| 02/26/02 | $1.020 | +2.00% | 34,46,560 |
| 01/26/01 | $1.000 | -2.91% | 50,58,462 |
| 30/26/30 | $1.030 | -5.50% | 73,22,871 |
| 29/26/29 | $1.090 | +5.83% | 75,56,448 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OCGN Stock
Select your edition
All financial news and data tailored to specific country editions
